| Epitope mapping: the first step in developing epitope-based vaccines JM Gershoni, A Roitburd-Berman, DD Siman-Tov, NT Freund, Y Weiss BioDrugs 21, 145-156, 2007 | 374 | 2007 |
| HIV vaccine design to target germline precursors of glycan-dependent broadly neutralizing antibodies JM Steichen, DW Kulp, T Tokatlian, A Escolano, P Dosenovic, ... Immunity 45 (3), 483-496, 2016 | 355 | 2016 |
| Sequential immunization elicits broadly neutralizing anti-HIV-1 antibodies in Ig knockin mice A Escolano, JM Steichen, P Dosenovic, DW Kulp, J Golijanin, D Sok, ... Cell 166 (6), 1445-1458. e12, 2016 | 303 | 2016 |
| Immunization for HIV-1 broadly neutralizing antibodies in human Ig knockin mice P Dosenovic, L von Boehmer, A Escolano, J Jardine, NT Freund, AD Gitlin, ... Cell 161 (7), 1505-1515, 2015 | 282 | 2015 |
| Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice AT McGuire, MD Gray, P Dosenovic, AD Gitlin, NT Freund, J Petersen, ... Nature communications 7 (1), 10618, 2016 | 182 | 2016 |
| Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity D Hagin, T Freund, M Navon, T Halperin, D Adir, R Marom, I Levi, S Benor, ... Journal of Allergy and Clinical Immunology 148 (3), 739-749, 2021 | 162 | 2021 |
| Pepitope: epitope mapping from affinity-selected peptides I Mayrose, O Penn, E Erez, ND Rubinstein, T Shlomi, NT Freund, ... Bioinformatics 23 (23), 3244-3246, 2007 | 161 | 2007 |
| Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller NT Freund, H Wang, L Scharf, L Nogueira, JA Horwitz, Y Bar-On, ... Science translational medicine 9 (373), eaal2144, 2017 | 157 | 2017 |
| Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo M Medina-Ramírez, F Garces, A Escolano, P Skog, SW de Taeye, ... Journal of Experimental Medicine 214 (9), 2573-2590, 2017 | 149 | 2017 |
| Stepwise prediction of conformational discontinuous B‐cell epitopes using the Mapitope algorithm EM Bublil, NT Freund, I Mayrose, O Penn, A Roitburd‐Berman, ... Proteins: Structure, Function, and Bioinformatics 68 (1), 294-304, 2007 | 110 | 2007 |
| Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope CO Barnes, HB Gristick, NT Freund, A Escolano, AY Lyubimov, ... Nature communications 9 (1), 1251, 2018 | 96 | 2018 |
| Lower serologic response to COVID-19 mRNA vaccine in patients with inflammatory bowel diseases treated with anti-TNFα H Edelman-Klapper, E Zittan, ABG Shitrit, KM Rabinowitz, I Goren, ... Gastroenterology 162 (2), 454-467, 2022 | 74 | 2022 |
| Tumor-reactive antibodies evolve from non-binding and autoreactive precursors RD Mazor, N Nathan, A Gilboa, L Stoler-Barak, L Moss, I Solomonov, ... Cell 185 (7), 1208-1222. e21, 2022 | 56 | 2022 |
| Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies H Wang, HB Gristick, L Scharf, AP West Jr, RP Galimidi, MS Seaman, ... Elife 6, e27389, 2017 | 55 | 2017 |
| A New Glycan-Dependent CD4-Binding Site Neutralizing Antibody Exerts Pressure on HIV-1 In Vivo NT Freund, JA Horwitz, L Nogueira, SA Sievers, L Scharf, JF Scheid, ... PLoS pathogens 11 (10), e1005238, 2015 | 52 | 2015 |
| Mapping a Neutralizing Epitope on the SARS Coronavirus Spike Protein: Computational Prediction Based on Affinity-selected Peptides MAW Tarnovitski Natalia, Matthews J. Leslie, Sui Jianhua, Gershoni M. Jonathan Journal of Molecular Biology 359 (1), 190-201, 2006 | 45 | 2006 |
| Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosis A Watson, H Li, B Ma, R Weiss, D Bendayan, L Abramovitz, ... Nature Communications 12 (1), 602, 2021 | 44 | 2021 |
| Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors M Mor, M Werbner, J Alter, M Safra, E Chomsky, JC Lee, S Hada-Neeman, ... PLoS Pathogens 17 (2), e1009165, 2021 | 42* | 2021 |
| Rapid seroconversion and persistent functional IgG antibodies in severe COVID-19 patients correlates with an IL-12p70 and IL-33 signature A Munitz, L Edry-Botzer, M Itan, R Tur-Kaspa, D Dicker, D Marcoviciu, ... Scientific Reports 11 (1), 3461, 2021 | 34 | 2021 |
| Phage display selection, analysis, and prediction of B cell epitopes NT Freund, D Enshell‐Seijffers, JM Gershoni Current protocols in immunology 86 (1), 9.8. 1-9.8. 30, 2009 | 31 | 2009 |
michel nussenzweigHHMI, The Rockefeller UniversityVerified email at rockefeller.edu
